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FLAVOXATE HYDROCHLORIDE BASED ON CYSTOMETRY：
 TI｛E SECOND REPORT－A SIMULTANEOUS CONTROL
       STUDY ON DOUBLE BLIND METHOD
Shigeru MiyAzAKi， Shuta ONo， Motonori FuRuKAwA，
    Kiyoshi MoMoi and Kunihiro KANEDA
From the DePartment of Urology， Osaka Medical College
    （Chairman： Prof． S． Miyaxalei， M． D．）
  Nineteen cases of nervous po11akisuria or fernale vesicopathy were treated with fiavoxate
600rng per day or placebo for one week． Cystometry was performed befo！e and after the
administration．
  1． Adrninistration of flavoxate gave rise to increase of both at minimum and maximum
desire to void， particularly that at the mlnimum desire．
  2．Resting intravesical pressure both at the皿inimum andπ1aximum desire to void did
not change signifieantly． Narnely， the pressure curve showed a decline．
  3． lt was’speculated that flavoxate might have some action on the center controlling
desire to void besides． its relaxing action on the vesical detrusor．
  4． Highly significant correlation was proved between the bladder volume at the’mini－
mum’ desire to void and the vesical capacity． Desire to void seemed to be activated by intra－
vesical pressure rather than by vesical distention．
は じ め に
 著者は第1報において，正常成人女子ならびにあら
かじめ塩化bethanechole chlorideを撲与した患者


















 Flavoxate錠（1錠i中 flavoxate hydrochloride
200m9含有）およびplacebo（乳糖・デンプン適量）




















































































































































































































































































































856         宮崎iほか：Flavoxate hydrochloride・膀胱内圧測定
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 Signlficant at o．s％ level













   Table 8．両群における最小尿意変化量
















































t一検定 ’＝5．224＞3．965 ・ to．oo1（φ皿17）
    Significant at O．1％ level
宮崎・ほか二Flavoxate hydrochloride・膀胱内圧測定
群間の検定をおこなった．
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一ト0．5 一〇． 1
Table 9．投与前後の最：小尿意量の変化率
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858         宮崎・ほか：Flavoxate hydroch1。ride・膀胱内圧測定
  Table 12・隔心における膀胱容量の増加率       Table 14．両脇における最：高意識圧変化値
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